HIGHLIGHTS
- who: Yasuyuki Saito and collaborators from the Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, Japan have published the Article: The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity, in the Journal: Cancers 2022, 14, 1976. of /2022/
- what: Experimental and clinical studies have revealed that not only cDC1s but also cDC2s contribute to the induction of antitumor immunity. cDC2s are more abundant in lymphoid tissues as well as in peripheral blood than are cDC1s . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.